As part of the implementation of the Affordable Care Act, a series of state health insurance... Watch Video
NPC at a Glance
NPC is a health policy research organization focused on the critical issues of evidence, the value of medicines for patients, and innovation...more
CER
Do stakeholders think comparative effectiveness research is having an impact on health care decision making? Which organizations are viewed as the leaders on prioritizing, funding, and conducting research? Download our new booklet to find out...more
Value of Rx
Recent NPC research has focused on defining the optimal role and value of pharmaceuticals in the evolving payment and delivery models...more
Individual Treatment Effects
Being "unique" can impact your health care treatments. Learn more about the challenges of individual treatment effects...more
RECENT NEWS
CER Tweets of the Week (June 3-7, 2013)
The Patient-Centered Outcomes Research Institute (PCORI) generated buzz on Twitter this week with the... moreCER Tweets of the Week (May 27-31, 2013)
This week, stakeholders discussed new Agency for Healthcare Research and Quality (AHRQ) reports on health care... moreCER Tweets of the Week (May 20-24, 2013)
This week, Twitter users shared the Patient-Centered Outcomes Research Institute’s (PCORI) guide to applying for... more
E.V.I.dently May 2013
Message From NPC The Role of Pharmaceuticals in Health Insurance Exchanges One of the most pressing issues in... more
The Role of Pharmaceuticals in Health Insurance Exchanges
One of the most pressing issues in the implementation of the Affordable Care Act (ACA) is whether the state... moreAccess to Care Message
This is a test access to care message body.Report on Opportunity for Pharmaceutical Companies to Contribute to Value-Based Care
According to a new study by management consulting firm Oliver Wyman, physicians say that biopharmaceutical... moreShare Your Thoughts on AHRQ Effective Health Care Program’s Documents
In February, the Agency for Healthcare Research and Quality’s Effective Healthcare Program produced several... more
Astellas Joins the National Pharmaceutical Council
Washington, D.C. (May 14, 2013)—The National Pharmaceutical Council (NPC) today announced that Astellas... moreNPC Welcomes Dr. Bryan Luce as PCORI Chief Science Officer
WASHINGTON, DC (April 24, 2013) The National Pharmaceutical Council today welcomed the news that the Patient-... moreNPC Survey Shows Health Care Stakeholders Continue to Show Optimism About Future Role of Comparative Effectiveness Research
(Washington, DC, March 19, 2013)—As the implementation of the Affordable Care Act (ACA) picks up speed, a new... moreNational Pharmaceutical Council Welcomes Amgen as Its Newest Member
Washington, D.C. (January 16, 2013)—The National Pharmaceutical Council (NPC) today welcomed biotechnology... more
The State of CER and the Environment for Health Care Decision Making
This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (... moreKeeping Our Eye on the CER Ball
Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington... moreLeveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?
A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint... moreLiving Up to Its Name? The Role of Patient-Centered Research
Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a... more
Why Real-World Evidence Matters
National Pharmaceutical Council Director of Comparative Effectiveness Research Dr. Jennifer Graff explains the... moreAccountable Care Organization and a Framework for Biopharmaceuticals
National Pharmaceutical Council Chief Science Officer Dr. Robert Dubois discusses the many considerations faced... moreChallenges With Real-World Evidence
National Pharmaceutical Council Chief Science Officer Dr. Robert Dubois explains that how a drug might-or might... moreUsing Distributed Data Networks to Understand Heterogeneity in Real-World Data
Kimberly Westrich, director of health services research at the National Pharmaceutical Council, explains how... moreCER Tweets of the Week (June 3-7, 2013)
The Patient-Centered Outcomes Research Institute (PCORI) generated buzz on Twitter this week with the... moreCER Tweets of the Week (May 27-31, 2013)
This week, stakeholders discussed new Agency for Healthcare Research and Quality (AHRQ) reports on health care... moreCER Tweets of the Week (May 20-24, 2013)
This week, Twitter users shared the Patient-Centered Outcomes Research Institute’s (PCORI) guide to applying for... moreNPC Presentations at the ISPOR 18th Annual International Meeting
NPC staff members and collaborators presented on several recent research projects at the International Society... moreNEWS FEEDS
PUBLICATION
Understanding What Works - Evaluating the Evidence with Both Eyes Open
NPC's Drs. Dubois and Graff address the pitfalls of solely considering data from only a portion of the evidence available and the insights that can be gained from non-randomized or observational studies to assess treatments in usual care settings.
Learn MoreEVENT
AcademyHealth 2013 Annual Research Meeting
Visit NPC’s exhibition booth (#406) at the meeting - be sure to stop by and check out our latest research.
June 23-25, 2013
Baltimore Convention Center
Baltimore, MD
NEWS
Astellas Joins the National Pharmaceutical Council
Astellas Scientific and Medical Affairs, Inc. (Astellas), a U.S. affiliate of Tokyo-based Astellas Pharma Inc., has joined NPC as its newest member.